GIGLIOTTI, Casimiro Luca
 Distribuzione geografica
Continente #
NA - Nord America 2.678
EU - Europa 2.237
AS - Asia 1.424
SA - Sud America 180
Continente sconosciuto - Info sul continente non disponibili 94
AF - Africa 66
OC - Oceania 2
Totale 6.681
Nazione #
US - Stati Uniti d'America 2.559
RU - Federazione Russa 543
SG - Singapore 440
IE - Irlanda 358
IT - Italia 354
CN - Cina 336
DE - Germania 330
HK - Hong Kong 188
VN - Vietnam 181
SE - Svezia 179
BR - Brasile 128
UA - Ucraina 101
FR - Francia 90
GB - Regno Unito 90
IN - India 79
CA - Canada 70
FI - Finlandia 61
BD - Bangladesh 51
KR - Corea 39
PL - Polonia 26
BJ - Benin 25
ES - Italia 23
MX - Messico 21
ZA - Sudafrica 21
ID - Indonesia 20
CZ - Repubblica Ceca 18
IR - Iran 18
AR - Argentina 17
NL - Olanda 15
JP - Giappone 14
AT - Austria 12
CO - Colombia 11
IQ - Iraq 10
EC - Ecuador 9
TR - Turchia 9
LT - Lituania 7
VE - Venezuela 7
BE - Belgio 6
GR - Grecia 6
JM - Giamaica 6
CL - Cile 5
CR - Costa Rica 5
JO - Giordania 5
KE - Kenya 5
PH - Filippine 5
EU - Europa 4
LB - Libano 4
MD - Moldavia 4
NI - Nicaragua 4
BG - Bulgaria 3
DK - Danimarca 3
DZ - Algeria 3
GE - Georgia 3
MY - Malesia 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BB - Barbados 2
DO - Repubblica Dominicana 2
EG - Egitto 2
ET - Etiopia 2
HN - Honduras 2
KW - Kuwait 2
KZ - Kazakistan 2
MA - Marocco 2
PE - Perù 2
QA - Qatar 2
RO - Romania 2
SA - Arabia Saudita 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AU - Australia 1
AZ - Azerbaigian 1
BM - Bermuda 1
CG - Congo 1
CI - Costa d'Avorio 1
CW - ???statistics.table.value.countryCode.CW??? 1
DM - Dominica 1
EE - Estonia 1
GT - Guatemala 1
IL - Israele 1
LC - Santa Lucia 1
LK - Sri Lanka 1
ML - Mali 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
PY - Paraguay 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 6.593
Città #
Dublin 355
San Jose 322
Hong Kong 188
Singapore 180
Ashburn 171
Jacksonville 165
Council Bluffs 134
Chandler 88
Beijing 86
Dearborn 85
Los Angeles 75
Moscow 71
Dallas 70
Phoenix 61
Columbus 58
Munich 55
Wilmington 55
Ho Chi Minh City 52
Grafing 50
Novara 48
Lauterbourg 46
New York 46
Piemonte 42
Santa Clara 38
Seoul 37
Ann Arbor 36
Lawrence 36
Princeton 36
Buffalo 35
Hanoi 35
Turin 32
Milan 31
Cotonou 25
San Mateo 24
São Paulo 24
Vercelli 24
Toronto 23
Chicago 22
Helsinki 22
Frankfurt am Main 20
Denver 19
Falkenstein 19
Warsaw 19
Orem 18
Poplar 18
The Dalles 18
Düsseldorf 17
Bremen 16
Brooklyn 16
London 16
Atlanta 15
Brno 15
Johannesburg 14
Monmouth Junction 14
Amsterdam 13
Guangzhou 13
Montreal 13
Chennai 12
Tokyo 12
Andover 11
Mülheim 11
Rome 11
Boardman 10
Boston 10
Houston 10
Jakarta 10
Redondo Beach 10
St Louis 10
Mumbai 9
Nuremberg 9
San Giuliano Milanese 9
Zanjan 9
Can Tho 8
Da Nang 8
Dong Ket 8
Mexico City 8
Norwalk 8
Querétaro 8
Stockholm 8
Baghdad 7
Belo Horizonte 7
Charlotte 7
Hefei 7
Hillsboro 7
North Bergen 7
Olathe 7
San Diego 7
Shanghai 7
Torino 7
Vienna 7
Assago 6
Brussels 6
Cassano Magnago 6
Guayaquil 6
Haiphong 6
Las Vegas 6
Nanjing 6
San Francisco 6
Tianjin 6
Turku 6
Totale 3.622
Nome #
Immunotherapy of experimental melanoma with ICOS-Fc loaded in biocompatible and biodegradable nanoparticles 183
Differential induction of IL-17, IL-10, and IL-9 in human T helper cells by B7h and B7.1. 167
B7h Triggering Inhibits the Migration of Tumor Cell Lines 165
Osteopontin binds ICOSL promoting tumor metastasis 163
A mutation in caspase-9 decreases the expression of BAFFR and ICOS in patients with immunodeficiency and lymphoproliferation 157
Role of Anti-Osteopontin Antibodies in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis 156
Subcutaneous inverse vaccination with PLGA particles loaded with a MOG peptide and IL-10 decreases the severity of experimental autoimmune encephalomyelitis 155
B7h triggering inhibits umbilical vascular endothelial cell adhesiveness to tumor cell lines and polymorphonuclear cells 154
ICOS-Ligand Triggering Impairs Osteoclast Differentiation and Function In Vitro and In Vivo 151
Inducible t-cell costimulator ligand plays a dual role in melanoma metastasis upon binding to osteopontin or inducible t-cell costimulator 150
Enhanced cytotoxic effect of camptothecin nanosponges in anaplastic thyroid cancer cells in vitro and in vivo on orthotopic xenograft tumors 148
Decreased function of Fas and variations of the perforin gene in adult patients with primary immune thrombocytopenia 147
B7H triggering inhibits osteoclast function in vitro and in vivo 143
IL-17 protects T cells from apoptosis and contributes to development of ALPS-like phenotypes 140
Adaptive immune responses triggered by oxidative stress contribute to hepatic inflammation in NASH 139
Cutting-Edge Delivery Systems and Adjuvants in Tolerogenic Vaccines: A Review 138
Cholesteryl butyrate solid lipid nanoparticles inhibit the adhesion and migration of colon cancer cells 137
Specific transcriptional programs differentiate ICOS from CD28 costimulatory signaling in human Naïve CD4+ T cells 136
Extracellular proteasome-osteopontin circuit regulates cell migration with implications in multiple sclerosis 136
Genomic and functional evaluation of TNFSF14 in multiple sclerosis susceptibility 131
Thrombin Cleavage of Osteopontin Modulates Its Activities in Human Cells In Vitro and Mouse Experimental Autoimmune Encephalomyelitis In Vivo 128
In Vitro and In Vivo Therapeutic Evaluation of Camptothecin-Encapsulated β-Cyclodextrin Nanosponges in Prostate Cancer 126
Vitamin D Supplementation modulates ICOS+ and ICOS- regulatory T cell in siblings of Children with Type 1 Diabetes 125
Anti-rasburicase antibodies induce clinical refractoriness by inhibiting the enzyme catalytic activity 124
Role of the co-stimulatory molecule inducible T-cell co-stimulator ligand (ICOSL) in the progression of experimental metabolic dysfunction-associated steatohepatitis 123
ICOS-Fc as innovative immunomodulatory approach to counteract inflammation and organ injury in sepsis 119
Development and characterization of solid lipid nanoparticles loaded with a highly active doxorubicin derivative 118
Platelets: 'multiple choice' effectors in the immune response and their implication in COVID-19 thromboinflammatory process 118
Attenuation of immune-mediated influenza pneumonia by targeting the inducible co-stimulator (ICOS) molecule on T cells 117
Use of Poly Lactic-co-glycolic Acid Nano and Micro Particles in the Delivery of Drugs Modulating Different Phases of Inflammation 114
Platelets, Protean Cells with All-Around Functions and Multifaceted Pharmacological Applications 113
Eltrombopag second-line therapy in adult patients with primary immune thrombocytopenia in an attempt to achieve sustained remission off-treatment: results of a phase II, multicentre, prospective study 113
Solid lipid nanoparticles carrying temozolomide for melanoma treatment. Preliminary in vitro and in vivo studies 113
Glutathione/pH-responsive nanosponges enhance strigolactone delivery to prostate cancer cells 113
Differential Modulation of Human M1 and M2 Macrophage Activity by ICOS-Mediated ICOSL Triggering 110
Discovery of a septin-4 covalent binder with antimetastatic activity in a mouse model of melanoma 104
Electrospun Collagen Scaffold Bio-Functionalized with Recombinant ICOS-Fc: An Advanced Approach to Promote Bone Remodelling 103
ICOSL Stimulation by ICOS-Fc Accelerates Cutaneous Wound Healing In Vivo 103
The Gut-Brain-Immune Axis in Autism Spectrum Disorders: A State-of-Art Report 102
Optimization of an Injectable, Resorbable, Bioactive Cement Able to Release the Anti-Osteoclastogenic Biomolecule ICOS-Fc for the Treatment of Osteoporotic Vertebral Compression Fractures 99
Nanoemulsions as delivery systems for poly-chemotherapy aiming at melanoma treatment 99
Triggering of B7h by the ICOS modulates maturation and migration of monocyte-derived dendritic cells. 98
Sr-Containing Mesoporous Bioactive Glasses Bio-Functionalized with Recombinant ICOS-Fc: An In Vitro Study 97
Inducible T-cell co-stimulator (ICOS) and ICOS ligand are novel players in the multiple-myeloma microenvironment 97
Genes and Microbiota Interaction in Monogenic Autoimmune Disorders 96
Role of the C-terminal fragment of osteopontin in multiple sclerosis 95
Improvement in the anti-tumor efficacy of doxorubicin nanosponges in in vitro and in mice bearing breast tumor models 94
Exploiting Nanomedicine for Cancer Polychemotherapy: Recent Advances and Clinical Applications 91
Parenteral Nanoemulsions Loaded with Combined Immuno- and Chemo-Therapy for Melanoma Treatment 89
Paclitaxel-loaded nanosponges inhibit growth and angiogenesis in melanoma cell models 89
A Computational Model for the Release of Bioactive Molecules by the Hydrolytic Degradation of a Functionalized Polyester-Based Scaffold 89
G protein-coupled receptor 21 in macrophages: An in vitro study 88
Solid lipid nanoparticles of cholesteryl butyrate inhibit the proliferation of cancer cells in vitro and in vivo models. 78
Tuning of the immune response using peptides loaded in biocompatible and biodegradable nanoparticles 73
The Association of Axonal Damage Biomarkers and Osteopontin at Diagnosis Could Be Useful in Newly Diagnosed MS Patients 65
null 62
Totale 6.681
Categoria #
all - tutte 31.390
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.390


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022288 0 0 0 23 18 2 62 17 19 32 32 83
2022/2023825 47 38 59 12 55 69 29 46 391 14 44 21
2023/2024357 32 22 35 12 48 11 87 11 0 5 36 58
2024/2025754 28 4 38 16 32 59 69 81 174 52 32 169
2025/20262.898 133 117 193 400 323 208 427 428 196 236 195 42
2026/2027643 65 231 137 210 0 0 0 0 0 0 0 0
Totale 6.681